Faculty profile
Arezu Jahani-Asl
Back to facultyResearch
Read how they describe their research on their University of Ottawa profile.
Latest papers
Glycobiology-driven therapeutic targeting of glycan-binding proteins: mechanisms, diseases, and clinical translation.
Signal transduction and targeted therapy · 2026 · senior author
An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.
Signal transduction and targeted therapy · 2026 · senior author
REST/NRSF Preserves muscle stem cell identity by repressing alternate cell fate.
Nature communications · 2025
Latest funding
- $960,076
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
CIHR · 2024 · Nominated PI
- $100,000
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
CIHR · 2023 · Nominated PI
- $100,000
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
CIHR · 2022 · Nominated PI
24 publications.
Glycobiology-driven therapeutic targeting of glycan-binding proteins: mechanisms, diseases, and clinical translation.
Popatia AM, Sharanek A, Jahani-Asl A
An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.
Mansourabadi AH, Qu D, Cianci F, Snider J, Randhawa K, Raco L, Kotlyar M, Al Ayach M, Rey G, Sanghvi S, Abovsky M, Singh H, Luchman HA, Burger D, Rak J, Soleimani VD, Jurisica I, Stagljar I, Mazzanti M, Jahani-Asl A
REST/NRSF Preserves muscle stem cell identity by repressing alternate cell fate.
Sahinyan K, Blackburn DM, Simon MM, Lazure F, Kwan T, Wilson DH, Vahidyeganeh M, Alsadi N, von Maltzahn J, Yamada Y, Jahani-Asl A, Bourque G, Rudnicki MA, Soleimani VD
Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.
Burban A, Sharanek A, Hernandez-Corchado A, Najafabadi HS, Soleimani VD, Jahani-Asl A
Master regulators of neurogenesis: the dynamic roles of Ephrin receptors across diverse cellular niches.
Rasool D, Jahani-Asl A
The E3 ubiquitin ligase Nedd4L preserves skeletal muscle stem cell quiescence by inhibiting their activation.
Blackburn DM, Sahinyan K, Hernández-Corchado A, Lazure F, Richard V, Raco L, Perron G, Zahedi RP, Borchers CH, Lepper C, Kawabe H, Jahani-Asl A, Najafabadi HS, Soleimani VD
PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLS.
Rasool D, Burban A, Sharanek A, Madrigal A, Hu J, Yan K, Qu D, Voss AK, Slack RS, Thomas T, Bonni A, Picketts DJ, Soleimani VD, Najafabadi HS, Jahani-Asl A
Establishing Brain Tumor Stem Cell Culture from Patient Brain Tumors and Imaging Analysis of Patient-Derived Xenografts.
Mahmoudian E, Jahani-Asl A
Transcriptional reprogramming of skeletal muscle stem cells by the niche environment.
Lazure F, Farouni R, Sahinyan K, Blackburn DM, Hernández-Corchado A, Perron G, Lu T, Osakwe A, Ragoussis J, Crist C, Perkins TJ, Jahani-Asl A, Najafabadi HS, Soleimani VD
CLIC1 regulation of cancer stem cells in glioblastoma.
Randhawa K, Jahani-Asl A
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
Principal investigators: Jahani-Asl, Arezu
Keywords: Bfls; Ephrin Receptors; Gene Mutation; Phf6; Receptor; Signalling
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
Principal investigators: Jahani-Asl, Arezu
Keywords: Ephrin Receptors; Gene Mutation; Receptors; Signalling; Stem Cells; Transcription
Transcriptional Regulation of Impaired Neurogenesis in Developmental Disorders of Cognition and Intellectual Disability
Principal investigators: Jahani-Asl, Arezu
Keywords: Ephrin Receptors; Gene Mutation; Receptors; Signalling; Stem Cells; Transcription
Transcriptional Control of Glioma Stem Cells by a Novel LGALS1/HOXA5 Signalling Pathway
Principal investigators: Jahani-Asl, Arezu
Keywords: Hoxa5; Lgals1; Patient-Derived Stem Cells; Scrna-Seq; Self-Renewal; Transcription
Transcriptional Control of Glioma Stem Cells by a Novel LGALS1/HOXA5 Signalling Pathway
Principal investigators: Jahani-Asl, Arezu
Keywords: Glioblastoma; Hoxa5; Lgals1; Patient Derived Stem Cells; Self-Renewal; Transcription
Canada Research Chair - Tier 2
Principal investigators: Jahani-Asl, Arezu
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Cellular and Molecular Medicine
- Lady Davis Institute for Medical Research
- Pathology and Laboratory Medicine
- Human Genetics
- Rheumatology
- Biochemistry
- Pediatrics
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Arezu Jahani-Asl
Lady Davis Institute for Medical Research
11 shared papers, latest 2026
Ajoy Basak
Pathology and Laboratory Medicine
1 shared papers, latest 2007
Colin Crist
Faculty
1 shared papers, latest 2023
Igor Stagljar
Biochemistry
1 shared papers, latest 2026
Igor Jurisica
Rheumatology
1 shared papers, latest 2026
Janusz Rak
Pediatrics
1 shared papers, latest 2026
Dylan Burger
Cellular and Molecular Medicine
1 shared papers, latest 2026
Guillaume Bourque
Human Genetics
1 shared papers, latest 2025
Isabella Irrcher
Faculty
1 shared papers, latest 2015
Samuel Weiss
Cell Biology and Anatomy
1 shared papers, latest 2016
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.